title: Tacrolimus rescue therapy for renal transplant rejection.
authors.affiliation: Division of Urologic Surgery/Renal Transplantation, University of Pittsburgh Medical Center, Pennsylvania, USA.
authors.forename: M L
authors.initials: ML
authors.lastname: Jordan
authors.forename: R
authors.initials: R
authors.lastname: Shapiro
authors.forename: R
authors.initials: R
authors.lastname: Naraghi
authors.forename: D
authors.initials: D
authors.lastname: Smith
authors.forename: C
authors.initials: C
authors.lastname: Vivas
authors.forename: H A
authors.initials: HA
authors.lastname: Gritsch
authors.forename: V
authors.initials: V
authors.lastname: Scantlebury
authors.forename: P
authors.initials: P
authors.lastname: Randhawa
authors.forename: A J
authors.initials: AJ
authors.lastname: Demetris
authors.forename: J J
authors.initials: JJ
authors.lastname: Fung
authors.forename: T E
authors.initials: TE
authors.lastname: Starzl
mesh_terms: D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000473:pathology; D008297:Male; D011241:Prednisone / Q000627:therapeutic use; D012086:Reoperation; D016879:Salvage Therapy; D016559:Tacrolimus / Q000627:therapeutic use*
chemical_list: D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D011241:Prednisone; D016559:Tacrolimus